# Treatment of Advanced Head and Neck Cancer

> **NCT00982696** · PHASE2 · TERMINATED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Carcinoma, Squamous Cell of Head and Neck

## Interventions

- **BIOLOGICAL:** Opioid Growth Factor

## Key facts

- **NCT ID:** NCT00982696
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Deemed ineffective
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982696, "Treatment of Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00982696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
